Floatz logo

PRAZOSIN

Wounds and Injury

University of WashingtonSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Wounds and Injury cohort.

Asset / SponsorPhaseRating
TESTOSTERONE UNDECYLATE
Craig Hospital
Phase 4BB
Tranexamic Acid
Daniel Nishijima, MD, MAS
Phase 3BB
MIDAZOLAM
Baskent University
Phase 4BB
PROPRANOLOL
Hamad Medical Corporation
Phase 4BB
GLUCOSE, ANHYDROUS
Baskent University
Phase 4BB

View all 30 →

Same molecule, other indications

PRAZOSIN is also rated in:

Gastrointestinal HemorrhageDormant
BB
Indicative ·
69 / 100
View asset →
Post-Traumatic HeadacheDormant
BB
Indicative ·
69 / 100
View asset →
portal hypertensionDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →